Time-kill curves for a semisynthetic glycopeptide, LY333328, against vancomycin-susceptible and vancomycin-resistant Enterococcus faecium strains.

Documenti analoghi

• Synergy of an Investigational Glycopeptide, LY333328, with Once-Daily Gentamicin against Vancomycin-Resistant Enterococcus faecium in a Multiple-Dose, In Vitro Pharmacodynamic Model
  di: Zelenitsky, S. A., et al.
  Pubblicazione: (1999)
• In vitro kill curves of a new semisynthetic echinocandin, LY-303366, against fluconazole-sensitive and -resistant Candida species.
  di: Karlowsky, J A, et al.
  Pubblicazione: (1997)
• In vitro antibacterial activity of LY333328, a new semisynthetic glycopeptide.
  di: Biavasco, F, et al.
  Pubblicazione: (1997)
• Influence of Human Serum on Pharmacodynamic Properties of an Investigational Glycopeptide, LY333328, and Comparator Agents against Staphylococcus aureus
  di: Zhanel, George G., et al.
  Pubblicazione: (1998)
• Pharmacodynamic evaluation of a new glycopeptide, LY333328, and in vitro activity against Staphylococcus aureus and Enterococcus faecium.
  di: Mercier, R C, et al.
  Pubblicazione: (1997)